Michael J. Wilkinson

2.4k citations

56 papers · 1.6k indexed · 2 hit papers · h-index 18

Impact in

Endocrine and Autonomic Systems top 2%
- Circadian rhythm and melatonin
Physiology top 5%
- Dietary Effects on Health
- Diet and metabolism studies

Papers in

Architecture 1
Surgery 28
- Lipoproteins and Cardiovascular Health 23

Co-authors: Pam R. Taub Adena Zadourian Emily N. C. Manoogian Satchidananda Panda Jason Fleischer Xinran Wang Hannah Lo Saket Navlakha
Journals: Journal of clinical lipidology (5 papers)Journal of the American Heart Association (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Journal of the American College of Cardiology (2 papers)Cell Metabolism (1 paper)
Partner nations: United States United Kingdom Canada

In The Last Decade

Michael J. Wilkinson

51 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice 2024 · 127 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Journal of clinical lipidology
2019 Cell Metabolism

Peers

Countries citing papers authored by Michael J. Wilkinson

Since Specialization

Citations

This map shows the geographic impact of Michael J. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Wilkinson more than expected).

Fields of papers citing papers by Michael J. Wilkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Wilkinson. The network helps show where Michael J. Wilkinson may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Wilkinson Line = papers co-authored together Michael J. Wilkinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lipoprotein(a) testing trends in young ischemic stroke patients from 2015-2024: An analysis of 188,000 individuals Journal of Stroke and Cerebrovascular Diseases ·Я.І. Ковальчук, Brett C. Meyer, Félix López de Felipe, Raphael Cuomo, Michael J. Wilkinson, Ehtisham Mahmud, Pam R. Taub, Harpreet Bhatia, Mattheus Ramsis	2025	0
2	Global lipoprotein (a) testing trends from 2015 to 2023 American Heart Journal ·Muhammad Farhan Hanif, Choumessi Tchewonpi Aphrodite, M.J. Sáenz-Sanjuan, Harpreet Bhatia, Michael J. Wilkinson, Ahmed Mustafa Rashid, Nicholas Chew, Subhash Banerjee, A. Roblin, Michael D. Shapiro, Ziyang Ruan	2025	0
3	Lipoprotein(a) Testing Trends in the United States 2015-2024 JACC Advances ·Mattheus Ramsis, Я.І. Ковальчук, Hs Dang, Michael J. Wilkinson, Ehtisham Mahmud, Pam R. Taub, Harpreet Bhatia	2025	1
4	Insights from a real-world experience with inclisiran at a large United States lipid clinic Journal of clinical lipidology ·Celina Santos Boga Marques Porto, Franklin Jorge, 修越村, Hyeong-Sik 신형식Shin, Michael J. Wilkinson	2025	0
5	Unique features of dyslipidemia in women across a lifetime and a tailored approach to management SHILAP Revista de lepidopterología ·Yeon-Mo Yang, Е. С. Белкина, Michael J. Wilkinson, Pam R. Taub	2024	11
6	Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery disease SHILAP Revista de lepidopterología ·Michael J. Wilkinson, P. Debye, Dinh Thi Trinh, Manuel Carrasco Zalvide y María Ter Castillo, Ronghui Xu, Pam R. Taub	2023	0
7	Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes Current Cardiology Reports ·S. Gary, 修越村, Michael J. Wilkinson	2023	2
8	Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum Journal of the American Heart Association ·Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos	2023	26
9	Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis Atherosclerosis ·Harpreet Bhatia, S. Gary, Adam Taleb, Michael J. Wilkinson, Andrew M. Kahn, Bruno Cotter, Calvin Yeang, Anthony N. DeMaria, Mitul Patel, Ehtisham Mahmud, Ryan Reeves, Sotirios Tsimikas	2022	18
10	Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic Journal of clinical lipidology ·修越村, 真男熊谷, Pam R. Taub, Michael J. Wilkinson	2022	15
11	Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship The American Journal of Cardiology ·Michael J. Wilkinson, Adena Zadourian, Pam R. Taub	2019	23
12	DEDICATED PROGRAM TO ENHANCE MEASUREMENT OF LIPOPROTEIN(A) AMONG PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT Journal of the American College of Cardiology ·Gary Ma, Michael J. Wilkinson, Calvin Yeang, M Feldner-Busztin, Anthony N. DeMaria, Bruno Cotter, Ryan Reeves, Mitul Patel, Ehtisham Mahmud, Sotirios Tsimikas	2018	1
13	Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis Current Opinion in Cardiology ·Calvin Yeang, Michael J. Wilkinson, Sotirios Tsimikas	2016	57
14	Overcoming toxicity and side-effects of lipid-lowering therapies Best Practice & Research Clinical Endocrinology & Metabolism ·Michael J. Wilkinson, Luke J. Laffin, Michael H. Davidson	2014	44
15	Recent Developments in the Treatment of Familial Hypercholesterolemia: A Review of Several New Drug Classes Current Treatment Options in Cardiovascular Medicine ·Michael J. Wilkinson, Michael H. Davidson	2013	2
16	Personalized Decision Support in Type 2 Diabetes Mellitus: Current Evidence and Future Directions Current Diabetes Reports ·Michael J. Wilkinson, Aviva G. Nathan, Elbert S. Huang	2012	24
17	Orbital Involvement in Extranodal Natural Killer T Cell Lymphoma: An Atypical Case Presentation and Review of The Literature Orbit ·Özge Özalp, I.E. Ravshanova, Jeffrey M. Sundstrom, Jozef Malysz, Charles A. Specht, Michael J. Wilkinson	2012	23
18	Adjuvant Antiangiogenic Therapy for Giant Cell Tumors of the Jaws Journal of Oral and Maxillofacial Surgery ·Leonard B. Kaban, Maria J. Troulis, Michael J. Wilkinson, David H. Ebb, Thomas B. Dodson	2007	61
19	Love is not a marketable commodity: new public management in the British National Health Service Journal of Advanced Nursing ·Michael J. Wilkinson	1995	13
20	MMAF for advanced gastric cancer European Journal of Cancer and Clinical Oncology ·Heather Anderson, J.H. Scarffe, Malcolm Ranson, Dimitar Minev, M Dougal, Inga Samkharadze, Michael J. Wilkinson, Emmmanuel Ifeanyi Victor	1991	3

About Michael J. Wilkinson

Michael J. Wilkinson is a scholar working on Architecture, Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Pharmaceutical Economics and Policy (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Nutritional Studies and Diet (3 papers), Diet and metabolism studies (3 papers) and Acute Myocardial Infarction Research (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (348 citations), Physiology (612 citations), Aging (32 citations), Endocrinology, Diabetes and Metabolism (244 citations) and Cancer Research (167 citations). Michael J. Wilkinson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Pam R. Taub, Adena Zadourian, Emily N. C. Manoogian, Satchidananda Panda, Jason Fleischer, Xinran Wang, Hannah Lo, Saket Navlakha, Sotirios Tsimikas and Anthony Howell. Their work appears in journals such as Journal of clinical lipidology, Journal of the American Heart Association, Arteriosclerosis Thrombosis and Vascular Biology, Journal of the American College of Cardiology and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact